SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,478,554 | -34.3% | 9,167,585 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $54,000,092 | +81.8% | 9,060,418 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $29,710,997 | -16.1% | 9,085,932 | +1.3% | 0.00% | 0.0% |
| Q4 2022 | $35,418,208 | -33.2% | 8,966,635 | +1.4% | 0.00% | -50.0% |
| Q3 2022 | $53,040,000 | +2.4% | 8,839,881 | +9.8% | 0.00% | +100.0% |
| Q2 2022 | $51,777,000 | -18.3% | 8,052,411 | +5.0% | 0.00% | 0.0% |
| Q1 2022 | $63,351,000 | -46.9% | 7,669,682 | -0.5% | 0.00% | -66.7% |
| Q4 2021 | $119,322,000 | -30.2% | 7,708,151 | +1.6% | 0.00% | -25.0% |
| Q3 2021 | $170,895,000 | +253.2% | 7,588,544 | +208.3% | 0.00% | +300.0% |
| Q2 2021 | $48,387,000 | -37.9% | 2,461,181 | +5.7% | 0.00% | -50.0% |
| Q1 2021 | $77,906,000 | – | 2,327,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $1,145,980,000 | 18.35% |
| Trustees of Columbia University in the City of New York | 281,250 | $9,414,000 | 11.41% |
| Alphabet Inc. | 2,812,500 | $94,134,000 | 3.80% |
| Omega Fund Management, LLC | 843,750 | $28,240,000 | 2.67% |
| EMJ Capital Ltd. | 200,000 | $6,694,000 | 1.48% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,131,249 | $138,273,000 | 0.89% |
| HARVARD MANAGEMENT CO INC | 468,749 | $15,689,000 | 0.88% |
| Dragoneer Investment Group | 1,500,000 | $50,205,000 | 0.72% |
| Avidity Partners Management LP | 732,321 | $24,511,000 | 0.68% |
| SB Management Ltd | 2,625,153 | $87,864,000 | 0.57% |